Formation Bio

Formation Bio

Signal active

Investment Firm

Overview

Formation Bio is a biotechnology company that focuses on drug development to provide new treatments to patients faster by reimagining clinical trials.

Highlights

Founded

2013

Industry

Biotechnology

Employees

101-250

Investment

1

Lead Investment

0

Exits

undefined

Stages

Early Stage Venture

Investor Type

N/A

Location

New York, New York, United States, North America

Contact Information

Social

Profile Resume

Formation Bio, established in 2013 and headquartered in New York, New York, United States, North America., specializes in Early Stage Venture investments across Financial Services, FinTech, Online Portals, Consumer Lending, Credit, Venture Capital, Finance, InsurTech, Financial Exchanges, Information Services. Their recent investments include January, IA Ventures, Brewer Lane Ventures, GLG, Third Prime. The highest investment round they participated in was $1.5B. Among their most notable exits are January and IA Ventures. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace James Leslie

James Leslie

Chief Financial Officer

imagePlace Benjamine Liu

Benjamine Liu

CEO and Co-Founder

imagePlace Jorge Ramirez

Jorge Ramirez

Head of Investments and VP Business Development

imagePlace Linhao Zhang

Linhao Zhang

Co-Founder and COO

imagePlace Gavin Corcoran

Gavin Corcoran

Chief Medical Officer

imagePlace Melissa Kaplan Enbar

Melissa Kaplan Enbar

Chief People Officer

Investment portfolio

Formation Bio has made 1 investments. Their most recent investment was on Mar 30, 2022, when January raised $10.0M.

investments

1

Diversity investments

0

Lead investments

0

Number of exits

undefined

Investments

1

Annouced DateOrganization NameIndustryMoney Raised
Mar 30, 2022
January January
Financial Services10.0M

Exits

0

Funding Timeline

Funding rounds

1

Investors

19

Funds

0

Funding Rounds

1

Formation Bio has raised 1 rounds. Their latest funding was raised on Mar 30, 2022 from a Series A - January round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Mar 30, 2022
Series A - January Series A - January
-10.0M-

Investors

25

Formation Bio is funded by 25 investor(s). Sequoia Capital and Emerson Collective Kantor are the most recent investors.

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.